STARCEMENT.BO(STARCEMENT.BO)
STARCEMENT.BO
No analyst ratings available
No analyst price targets available for STARCEMENT.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $41.70B | $46.25B | $54.91B |
| Low | $39.97B | $43.49B | $52.11B |
| High | $44.60B | $51.82B | $60.20B |
| EBITDA Avg | $8.43B | $9.35B | $11.10B |
| Low | $8.08B | $8.79B | $10.53B |
| High | $9.02B | $10.47B | $12.17B |
| EBIT Avg | $5.42B | $6.01B | $7.14B |
| Low | $5.20B | $5.66B | $6.78B |
| High | $5.80B | $6.74B | $7.83B |
| Net Income Avg | $4.15B | $4.55B | $5.05B |
| Low | $3.59B | $3.76B | $4.72B |
| High | $4.57B | $5.00B | $5.69B |
| EPS Avg | $10.27 | $11.24 | $12.50 |
| Low | $8.89 | $9.30 | $11.67 |
| High | $11.31 | $12.36 | $14.06 |
| Analysts (Rev / EPS) | 13 / 12 | 13 / 12 | 9 / 10 |